We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Design, Synthesis, Molecular Docking Analysis and Biological Evaluations of 4-[(Quinolin-4-yl)amino]benzamide Derivatives as Novel Anti-Influenza Virus Agents.
- Authors
Zhang, Chao; Tang, Yun-Sang; Meng, Chu-Ren; Xu, Jing; Zhang, De-Liang; Wang, Jian; Huang, Er-Fang; Shaw, Pang-Chui; Hu, Chun
- Abstract
In this study, a series of 4-[(quinolin-4-yl)amino]benzamide derivatives as the novel anti-influenza agents were designed and synthesized. Cytotoxicity assay, cytopathic effect assay and plaque inhibition assay were performed to evaluate the anti-influenza virus A/WSN/33 (H1N1) activity of the target compounds. The target compound G07 demonstrated significant anti-influenza virus A/WSN/33 (H1N1) activity both in cytopathic effect assay (EC50 = 11.38 ± 1.89 µM) and plaque inhibition assay (IC50 = 0.23 ± 0.15 µM). G07 also exhibited significant anti-influenza virus activities against other three different influenza virus strains A/PR/8 (H1N1), A/HK/68 (H3N2) and influenza B virus. According to the result of ribonucleoprotein reconstitution assay, G07 could interact well with ribonucleoprotein with an inhibition rate of 80.65% at 100 µM. Furthermore, G07 exhibited significant activity target PA−PB1 subunit of RNA polymerase according to the PA−PB1 inhibitory activity prediction by the best pharmacophore Hypo1. In addition, G07 was well drug-likeness based on the results of Lipinski's rule and ADMET prediction. All the results proved that 4-[(quinolin-4-yl)amino]benzamide derivatives could generate potential candidates in discovery of anti-influenza virus agents.
- Subjects
HONG Kong (China); MOLECULAR docking; BENZAMIDE; INFLUENZA B virus; RNA replicase; INFLUENZA A virus; RNA polymerases; NEURAMINIDASE
- Publication
International Journal of Molecular Sciences, 2022, Vol 23, Issue 11, p6307
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms23116307